Parathyroid resistance to FGF23 in kidney transplant recipients: back to the past or ahead to the future?

Kidney Int. 2010 Nov;78(10):953-5. doi: 10.1038/ki.2010.283.

Abstract

Fibroblast growth factor 23 (FGF23) modulates the metabolism of minerals and vitamin D. In chronic kidney disease (CKD), this process is disturbed owing to decreased parathyroid expression of FGF23's receptor complex Klotho-FGF receptor 1. In this issue, Krajisnik and colleagues demonstrate that similar alterations occur in parathyroid glands from kidney transplant recipients in association with a decline in allograft function. Is it possible that these data can be extrapolated to general early-stage CKD patients?

Publication types

  • Comment

MeSH terms

  • Chronic Disease
  • Fibroblast Growth Factor-23
  • Fibroblast Growth Factors / physiology*
  • Glucuronidase / physiology
  • Graft Rejection / physiopathology
  • Humans
  • Hyperplasia / pathology
  • Kidney Diseases / physiopathology*
  • Kidney Transplantation / physiology*
  • Klotho Proteins
  • Minerals / metabolism
  • Parathyroid Glands / pathology
  • Parathyroid Glands / physiopathology*
  • Receptors, Fibroblast Growth Factor / physiology
  • Transplantation, Homologous

Substances

  • FGF23 protein, human
  • Minerals
  • Receptors, Fibroblast Growth Factor
  • Fibroblast Growth Factors
  • Fibroblast Growth Factor-23
  • Glucuronidase
  • Klotho Proteins